• 2002

Company Description

EGEN develops delivery systems for the manufacture of nucleic acid and anti-cancer drugs.

EGEN, Inc., is an Alabama-based specialty biopharmaceutical company developing safe and efficient delivery systems to be used to create products for treatment of human diseases. Their synthetic biocompatible delivery vehicles can be used to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA) and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promoting uptake by the target cells and facilitating intracellular trafficking.